美股盤前要點 | 美國對半導體、藥品啟動232調查！標普500指數出現“死亡交叉”信號
1. 美國三大股指期貨齊跌，納指期貨跌0.33%，標普500指數期貨跌0.35%，道指期貨跌0.38%。 2. 歐股主要指數升跌不一，德國DAX指數升0.81%，英國富時100指數升0.74%，法國CAC指數跌0.02%，歐洲斯托克50指數升0.35%。3. 標普500指數出現“死亡交叉”信號——50日移動平均線向下穿破200日移動平均線，為2022年3月以來首見。4. 美國商務部已開始調查“半導體和半導體制造設備”以及“藥品和藥品成分，包括成品藥”進口對美國國家安全的影響。5. 英偉達承諾四年內投資5000億美元在美國生產AI服務器，特朗普：將加速向英偉達發放所有必要許可。6. IDC：蘋果iPhone首季出貨量同比增長10%至5790萬部，主要是由於微抵消關税而採取的囤貨措施。7. 消息稱中國已要求境內航司暫停接收波音飛機、停止從美國公司購買相關零組件和設備。8. Meta面臨歷史性反壟斷法庭審判，或被要求分拆Instagram及Facebook。9. 馬斯克宣佈，首個真正基於純人工智能的通用全自動駕駛方案即將面世。10. 台積電據稱將完成面板級先進芯片封裝(PLP)的研發，並計劃2027年開始小批量生產。11. 英特爾同意出售旗下可編程半導體生產分支Altera 51%權益，將套現34億美元。12. 奈飛高管設定目標，希望到2030年實現1萬億美元的市值。13. 阿里巴巴相關人士迴應“正積極參與星巴克中國股權競購”的消息：這是“假消息”。14. 美國芯片設備供應商應用材料買入荷蘭半導體先進封裝公司貝思半導體9%股權。15. 野村據報收縮中國財富管理業務，轉而優先擴展券商及資產管理業務。16. 美國谷物分銷集團ADM擬關閉在中國的國內貿易業務並裁員。17. 小鵬汽車首架飛行汽車“陸地航母”預計明年上市並啟動大規模交付，內地售價不超過30萬美元。18. 花旗Q1營收216億美元，預估213億美元；淨利潤增長21%至41億美元，合每股1.96美元。19. 強生Q1銷售額218.9億美元，預估215.8億美元；調整後每股收益2.77美元，預估2.6美元。20. 愛立信Q1銷售淨額550.3億瑞典克朗，預估555.1億瑞典克朗；調整後EBIT 62.1億瑞典克朗，預估50.9億瑞典克朗。美股時段值得關注的事件：20:30 美國4月紐約聯儲製造業指數/美國3月進口物價指數月率(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
